In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease.
In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease.
复制标题
全身性心肌疾病患者体内磷 31 光谱成像。
DOI:
10.1016/0002-9149(90)90331-t
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
Massie,B
中科院分区:
文献类型:
--
作者:
Schaefer,S;Gober,JR;Schwartz,GG;Twieg,DB;Weiner,MW;Massie,B
The goals of this study were to determine whether abnormalities in phosphorus metabolism could be noninvasively detected using phosphorus-31 nuclear magnetic resonance spectroscopy in patients with dilated cardiomyopathy and left ventricular hypertrophy, and whether these patient groups could be distinguished from each other based on parameters obtained using this technique. Seventeen patients and 14 control subjects were studied using nuclear magnetic resonance spectroscopy. Spectra were obtained from the human heart at rest using 3-dimensional spectroscopic imaging as a localization technique. Data were acquired over an average volume of 48 cc in 26.3 minutes using a 2 tesla imaging and spectroscopy unit. The ratio of phosphocreatine to adenosine triphosphate was 0.89 ± 0.08 (mean ± standard error) in normal subjects and did not differ significantly in patients with dilated cardiomyopathy or left ventricular hypertrophy. A prominent peak in the phosphodiester region was seen much more frequently in patients with dilated cardiomyopathy, resulting in significantly higher ratios of phosphodiester to phosphocreatine (1.28 ± 0.35) and phosphodiester to adenosine triphosphate (0.79 ± 0.18) in this group compared to normal subjects (0.33 ± 0.08 and 0.29 ± 0.08, respectively). However, the various patient groups could not be reliably distinguished from each other based on spectral patterns.These studies demonstrate the feasibility of performing phosphorus-31 nuclear magnetic resonance spectroscopic imaging in patients with myocardial disease. The initial results indicate that, under resting conditions, the ratio of phosphocreatine to adenosine triphosphate is not consistently altered in patients with severe global cardiomyopathies or hypertrophy. Phosphodiesters are elevated in some patients with dilated cardiomyopathy, a finding that may signify abnormal phospholipid metabolism in this condition.
登录
查看更多内容
影响因子:
--
作者:
M. Hunkapiller;R. Hewick;W. Dreyer;L. Hood
通讯作者:
L. Hood
DOI:
10.1099/0022-1317-7-3-267
发表时间:
1970
期刊:
The Journal of general virology
影响因子:
--
作者:
B. Cartwright;P. Talbot;F. Brown
通讯作者:
F. Brown
影响因子:
3.7
作者:
Leo Lefrançois;D. Lyles
通讯作者:
D. Lyles
影响因子:
5.4
作者:
MCSHARRY, JJ;WAGNER, RR
通讯作者:
WAGNER, RR
DOI:
--
发表时间:
1975
期刊:
影响因子:
--
作者:
R. Wagner
通讯作者:
R. Wagner